logo
welcome
ScienceDaily

ScienceDaily

Antibody-drug conjugate found effective against brain metastases in patients with HER2-positive breast cancer

ScienceDaily
Summary
Nutrition label

79% Informative

An antibody-drug conjugate found effective against brain metastases in patients with HER2-positive breast cancer.

Trastuzumab deruxtecan (T-DXd) delivers chemotherapy directly to tumors.

The findings reinforce earlier findings of the benefits of the drug in these patients.

Trastuzumab deruxtecan in HER2 -positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial.

The study is published in Nature Medicine , 2024 ; DOI: 10.1038 /s41591/024-024-032617.

VR Score

89

Informative language

95

Neutral language

68

Article tone

formal

Language

English

Language complexity

65

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

long-living

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links